Written answers
Tuesday, 4 November 2025
Department of Health
Departmental Data
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1840. To ask the Minister for Health the number and proportion of students in eligible schools immunisation cohort who received dose 1; completed the HPV vaccination course in each of the academic years 2019-2020 to 2024-2025; the figures in by sex (male/female), county, and CHO, including denominators used for coverage calculations, in tabular form; and if she will make a statement on the matter. [58794/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1841. To ask the Minister for Health the estimated number and proportion of the eligible school cohort with no HPV vaccination recorded in each of the academic years 2019-2020 to 2024-2025; the reasons recorded for non-vaccination (no consent, absent on day, contraindication, deferred, other); the actions being taken to reduce the non-vaccinated proportion in 2025-2026; and if she will make a statement on the matter. [58795/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1842. To ask the Minister for Health the number of catch-up HPV vaccinations administered outside the school programme since 1 January 2019 by age band (15-19, 20-26, 27-45 years), sex, CHO, and provider setting (GP, pharmacy, HSE clinic); the number completing full schedules; and if she will make a statement on the matter. [58796/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1843. To ask the Minister for Health the most recent mid-year uptake snapshot for the 2025-2026 school cohort, to include first-dose uptake and scheduled completion rate by sex and county; the communications and outreach measures funded in 2025-2026 to improve uptake, including targeted engagement with boys/young men, DEIS schools, migrant communities and medically vulnerable groups; and if she will make a statement on the matter. [58797/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1844. To ask the Minister for Health the annual number and age-standardised incidence of HPV-attributable cancers in Ireland over the past ten years, by site (cervix, oropharynx, anus, penis, vulva, vagina) and sex, with the proportion HPV-16 positive where available; the source methodology (e.g. NCRI linkage, p16/HPV genotyping); and if she will make a statement on the matter. [58798/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The National Cancer Registry Ireland (NCRI) is responsible for collecting data on the incidence of cancers. The Department of Health has contacted NCRI for the information requested in this question and they have supplied the information at the link below, which includes the most recent 10 years of data available.
Regarding the source methodology, the NCRI state that they extract information on the p16 result for a tumour where that result has been clearly stated by a histopathologist on a pathology report.
Cormac Devlin (Dún Laoghaire, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
1845. To ask the Minister for Health the distribution of stage at diagnosis and median age at diagnosis for HPV-16-positive oropharyngeal and anal cancers over the most recent five years; the median time from first presentation to diagnosis; and the actions being taken to shorten diagnostic intervals in primary care, dental services, and ENT pathways; and if she will make a statement on the matter. [58799/25]
Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The National Cancer Registry Ireland (NCRI) is responsible for collecting data on the incidence of cancers. Having reached out to the NCRI for the information requested in this question, staff there have supplied the distribution of stage at diagnosis and median age at diagnosis for p16-positive oropharyngeal and anal cancers over the most recent five years which is outlined in the following table.
Please note that I am informed by the NCRI that the term 'HPV-16-positive' is not typically used in pathology reporting. In practice it would be referred to as either 'HPV-positive' (indicating that the tumour tested positive for HPV) or 'p16-positive' (which refers to the presence of the p16 marker, commonly used as a surrogate indicator of HPV-related cancers). For the purposes of interpreting the question, the NCRI have assumed it refers to p16 positivity, as p16 immunohistochemistry has historically been the most widely used method.
In relation to the cancer site data, NCRI have provided figures for anal/rectal cancers rather than anal cancers alone. This reflects the grouping used in the NCRI's 2024 report on HPV-associated cancers.
Regarding the remainder of the question, I have asked the Health Service Executive to respond directly to the Deputy as soon as possible.
| - | p16 positive oropharyngeal | p16 positive anal/rectal cancers | ||
|---|---|---|---|---|
| stage at diagnosis 2018-2022 | Average annual case count | Proportion | Average annual case count | Proportion |
| I | <5 | 3% | 5 | 15% |
| II | 6 | 6% | 9 | 25% |
| III | 30 | 29% | 13.8 | 38% |
| IV | 54 | 52% | <5 | 8% |
| Unknown stage | 10 | 10% | 5 | 14% |
| median age at diagnosis 2018-2022 | 59 years | 62 years |
No comments